作者
Leanne LGC Ackermans, Joyce Rabou, M Basrai, A Schweinlin, SC Bischoff, O Cussenot, G Cancel-Tassin, RJ Renken, E Gómez, P Sánchez-González, A Rainoldi, G Boccia, KW Reisinger, Jan A Ten Bosch, Taco J Blokhuis
发表日期
2022/4/1
来源
Clinical Nutrition ESPEN
卷号
48
页码范围
36-44
出版商
Elsevier
简介
Background & aims
Sarcopenia is a muscle disorder associated with loss of muscle mass, strength and function. Early screening, diagnosis and treatment may improve outcome in different disease conditions. A wide variety of tools for estimation of muscle mass is available and each tool has specific technical requirements. However, different investigational settings and lack of homogeneity of populations influence the definition of gold standards, proving it difficult to systematically adopt these tools. Recently, the European Working Group on Sarcopenia in Older People (EWGSOP) published a revised recommendation (EWGSOP-2) and algorithm for using tools for screening and diagnosing sarcopenia. However, agreement of the EWGSOP2 criteria with other classifications is poor and although an overview of available tools is valuable, for the purpose of clinical decision-making the reverse is useful; a given …
引用总数
学术搜索中的文章
LLGC Ackermans, J Rabou, M Basrai, A Schweinlin… - Clinical Nutrition ESPEN, 2022